Coya Therapeutics (COYA) Accumulated Depreciation & Amortization (2022 - 2024)
Coya Therapeutics (COYA) has disclosed Accumulated Depreciation & Amortization for 3 consecutive years, with $98216.0 as the latest value for Q4 2024.
- Quarterly Accumulated Depreciation & Amortization rose 38.62% to $98216.0 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $98216.0 through Dec 2024, up 38.62% year-over-year, with the annual reading at $98216.0 for FY2024, 38.62% up from the prior year.
- Accumulated Depreciation & Amortization hit $98216.0 in Q4 2024 for Coya Therapeutics, up from $70855.0 in the prior quarter.
- In the past five years, Accumulated Depreciation & Amortization ranged from a high of $98216.0 in Q4 2024 to a low of $43494.0 in Q4 2022.
- Historically, Accumulated Depreciation & Amortization has averaged $70855.0 across 3 years, with a median of $70855.0 in 2023.
- Biggest five-year swings in Accumulated Depreciation & Amortization: soared 62.91% in 2023 and later soared 38.62% in 2024.
- Year by year, Accumulated Depreciation & Amortization stood at $43494.0 in 2022, then surged by 62.91% to $70855.0 in 2023, then surged by 38.62% to $98216.0 in 2024.
- Business Quant data shows Accumulated Depreciation & Amortization for COYA at $98216.0 in Q4 2024, $70855.0 in Q4 2023, and $43494.0 in Q4 2022.